Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Short Communication

Volume 5, Number 1, February 2013, pages 57-60


Deferasirox Reduces Oxidative Stress in Patients With Transfusion Dependency

Figure

Figure 1.
Figure 1. Clinical course of case 1.

Table

Table 1. Clinical Data Before and After Deferasirox Treatment
 
Case no.DiagnosisBefore deferasirox treatmentDurationAfter treatment
age sexferritin
(ng/mL)
dROM
(Carr U)
Hb
(g/dL)
ferritindROMHb
MDS: myelodysplastic syndrome; AA: aplastic anemia; MM: multiple myeloma; Hb: hemoglobin.
case 1MDS 75F1,9716034.55 Mo1,0313494.5
case 2MDS 67M8,0153915.74 Mo3,4641984.4
case 3MDS 72M2,6692327.98 Mo1,3572606.6
case 4MDS 80F7,7403637.75 Mo3,7203897.3
case 5AA 80F2,1214076.115 Mo1,6083237.8
case 6AA 73M3,6454895.73 Mo3,7133986.0
case 7AA 52M8255835.94 Mo2832925.1
case 8AA 45F4,2002996.84 Mo4,6392586.7
case 9MM 75M2,1723177.98 Mo2,1723116.2
mean3,7064096.52,4433096.1
SD2,5581271.21,488651.2